ArticleInvestigative ophthalmology & visual science2026
Mouse Lacrimal Gland Ductal Organoids With Controlled Polarity: A Novel Ex Vivo Research Model.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The aim of the present study was to develop a methodology for the culture and maintenance of ductal organoids derived from isolated lacrimal gland (LG) ducts, as well as to develop an approach for experimentally controlling epithelial polarity (apical-out [AO] versus apical-in [AI]). Methods: Intra- and interlobular ducts were microdissected from the LG of FVB/N mice aged 12 to 24 weeks. Isolated ductal segments were embedded in Matrigel and expanded in defined media. AO polarity was achieved using baseline medium, whereas AI polarity was induced by a 3-day treatment with R-spondin, Wnt-3a, noggin, and Y-27632, followed by maintenance in baseline medium supplemented with forskolin. Epithelial polarity and ductal lineage identity were assessed by immunofluorescence staining for CFTR, AQP4, VPAC1/2, and NKCC1. Secretagogue-induced changes in organoid volume were quantified by video-microscopy. Results: Organoids formed within 7 to 10 days and were successfully passaged through passage 7 without detectable loss of morphological characteristics. CFTR exhibited apical localization, whereas AQP4 localized to the basolateral membrane. VPAC1/2 expression showed a mosaic pattern across passages. NKCC1 proteins were expressed predominantly on the basolateral surface of the organoids. In AO cultures, stimulation with secretagogues induced a significant reduction in the organoid projected area, consistent with net fluid secretion. In contrast, AI organoids exhibited stimulus-evoked alterations in luminal density without a corresponding change in the total projected area. Conclusions: Duct-derived organoids retain key molecular features of native ductal epithelium, exhibit experimentally controllable epithelial polarity. This platform provides a versatile system for investigating ductal physiology and for the development of duct-targeted therapeutic strategies for dry eye disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.